GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livewire Ergogenics Inc (OTCPK:LVVV) » Definitions » EV-to-EBITDA

Livewire Ergogenics (Livewire Ergogenics) EV-to-EBITDA : -12.14 (As of May. 04, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Livewire Ergogenics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Livewire Ergogenics's enterprise value is $12.65 Mil. Livewire Ergogenics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 was $-1.04 Mil. Therefore, Livewire Ergogenics's EV-to-EBITDA for today is -12.14.

The historical rank and industry rank for Livewire Ergogenics's EV-to-EBITDA or its related term are showing as below:

LVVV' s EV-to-EBITDA Range Over the Past 10 Years
Min: -12.31   Med: 0   Max: 0
Current: -12.14

LVVV's EV-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 14.53 vs LVVV: -12.14

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-04), Livewire Ergogenics's stock price is $0.002. Livewire Ergogenics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.001. Therefore, Livewire Ergogenics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Livewire Ergogenics EV-to-EBITDA Historical Data

The historical data trend for Livewire Ergogenics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livewire Ergogenics EV-to-EBITDA Chart

Livewire Ergogenics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
EV-to-EBITDA
Get a 7-Day Free Trial - -145.05 -9.47 -2.36 -0.44

Livewire Ergogenics Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.23 -0.44 -0.63 - -

Competitive Comparison of Livewire Ergogenics's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Livewire Ergogenics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livewire Ergogenics's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livewire Ergogenics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Livewire Ergogenics's EV-to-EBITDA falls into.



Livewire Ergogenics EV-to-EBITDA Calculation

Livewire Ergogenics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12.651/-1.042
=-12.14

Livewire Ergogenics's current Enterprise Value is $12.65 Mil.
Livewire Ergogenics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Livewire Ergogenics  (OTCPK:LVVV) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Livewire Ergogenics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.002/-0.001
=At Loss

Livewire Ergogenics's share price for today is $0.002.
Livewire Ergogenics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Livewire Ergogenics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Livewire Ergogenics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Livewire Ergogenics (Livewire Ergogenics) Business Description

Traded in Other Exchanges
N/A
Address
1600 N Kraemer Boulevard, Anaheim, CA, USA, 92806-1410
Livewire Ergogenics Inc is operating in the cannabis-related health and wellness industry. It focused on acquiring special-purpose real estate properties conducive to the production of handcrafted and organically grown cannabis products for medical and recreational adult use in California. The company is based in Anaheim, California, and operates its main facility in Paso Robles.
Executives
Richard O Weed director, officer: Secretary 4695 MACARTHUR COURT STE 1430, NEWPORT BEACH CA 92660

Livewire Ergogenics (Livewire Ergogenics) Headlines

From GuruFocus

LiveWire Ergogenics Reports Third Quarter 2020 Results

By Marketwired Marketwired 11-16-2020